TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 288 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q3 2021. The put-call ratio across all filers is 0.44 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3 | -84.2% | 167 | -86.3% | 0.00% | – |
| Q2 2023 | $19 | +533.3% | 1,217 | +628.7% | 0.00% | – |
| Q1 2023 | $3 | 0.0% | 167 | 0.0% | 0.00% | – |
| Q4 2022 | $3 | -100.0% | 167 | -89.7% | 0.00% | – |
| Q3 2022 | $21,000 | +950.0% | 1,628 | +874.9% | 0.00% | – |
| Q2 2022 | $2,000 | -95.9% | 167 | -95.1% | 0.00% | – |
| Q1 2022 | $49,000 | -9.3% | 3,390 | -14.6% | 0.00% | – |
| Q4 2021 | $54,000 | -11.5% | 3,971 | +6.1% | 0.00% | – |
| Q3 2021 | $61,000 | -7.6% | 3,744 | -5.0% | 0.00% | – |
| Q2 2021 | $66,000 | +6.5% | 3,940 | +16.2% | 0.00% | – |
| Q1 2021 | $62,000 | +785.7% | 3,390 | +811.3% | 0.00% | – |
| Q3 2020 | $7,000 | +600.0% | 372 | +389.5% | 0.00% | – |
| Q3 2019 | $1,000 | 0.0% | 76 | +68.9% | 0.00% | – |
| Q2 2019 | $1,000 | -87.5% | 45 | -88.7% | 0.00% | – |
| Q1 2019 | $8,000 | – | 397 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Glenview Capital Management | 16,104,222 | $294,063,000 | 4.98% |
| GMT CAPITAL CORP | 2,468,695 | $45,078,000 | 3.31% |
| MANAGED ASSET PORTFOLIOS, LLC | 1,065,756 | $19,461,000 | 3.13% |
| Blackcrane Capital, LLC | 14,571 | $1,723,000 | 2.72% |
| BFAM Partners (Cayman) Ltd | 328,690 | $6,002,000 | 2.36% |
| Paulson & Co. | 4,727,415 | $86,323,000 | 1.98% |
| Mondrian Investment Partners LTD | 3,510,404 | $59,677,000 | 1.28% |
| Lumbard & Kellner, LLC | 135,550 | $2,264,000 | 0.80% |
| DAVIDSON INVESTMENT ADVISORS | 500,203 | $9,134,000 | 0.78% |
| TFG Asset Management GP Ltd | 589,390 | $10,762,000 | 0.77% |